Please login to the form below

Not currently logged in

FDA rejection

This page shows the latest FDA rejection news and features for those working in and with pharma, biotech and healthcare.

FDA rejects Takeda’s Eohilia after delays

FDA rejects Takeda’s Eohilia after delays

The company even announced its intended brand name for the treatment, Eohilia, yet these hopes now appeared to have been dashed by the FDA. ... The rejection by the FDA potentially clears the way for Sanofi’s Dupixent (dupilumab), which received

Latest news

More from news
Approximately 2 fully matching, plus 39 partially matching documents found.

Latest Intelligence

  • Pharma deals during February 2014 Pharma deals during February 2014

    This follows an FDA rejection due to its risk / benefit profile and demands for a further trial. ... According to Martin Shkreli, founder and CEO: “We also intend to move quickly to pursue FDA approval of Chenodal for CTX.".

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....